Figure 4.
Figure 4. Effect of repeat dosing of GSK3277329 (5 and 15 mg/kg subcutaneous injection once a day) on circulating neutrophil counts and the correlation with G-CSF levels in M fascicularis. (A) Neutrophil counts before, 6 hours after, and 24 hours after the first dose of GSK3277329 and the seventh dose. Significant difference compared with predose group (t = 0) determined by 2-way ANOVA followed by Sidak’s post hoc test (*P < .05, **P < .01). (B) Correlation plot between circulating G-CSF levels and neutrophil counts measured 6 hours after GSK3277329 administration, grouping all animals from both dosing groups and samples collected after the first and seventh dose (3 animals per dose group).

Effect of repeat dosing of GSK3277329 (5 and 15 mg/kg subcutaneous injection once a day) on circulating neutrophil counts and the correlation with G-CSF levels in M fascicularis. (A) Neutrophil counts before, 6 hours after, and 24 hours after the first dose of GSK3277329 and the seventh dose. Significant difference compared with predose group (t = 0) determined by 2-way ANOVA followed by Sidak’s post hoc test (*P < .05, **P < .01). (B) Correlation plot between circulating G-CSF levels and neutrophil counts measured 6 hours after GSK3277329 administration, grouping all animals from both dosing groups and samples collected after the first and seventh dose (3 animals per dose group).

Close Modal

or Create an Account

Close Modal
Close Modal